The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
526 - On an unbranded, consumer-facing, disease state website, it is permissible to discuss differential diagnosis? As in, could you "compare" the symptoms of the website condition with another, similar condition with overlapping symptoms?
-
I’ll presume you are referring to a help-seeking message or consumer brochure meeting all applicable requirements of the Health Canada policy document “The Distinction Between Advertising and Other Activities”. In that case, the answer is yes provided that the way you’ve executed the differential diagnosis does not render the piece to be advertising (e.g. does not favour or add emphasis to the sponsor’s product in a consumer brochure)
